Related Experiment Videos
Human skeletal muscle sodium channelopathies
S Vicart1, D Sternberg, B Fontaine
1Fédération de Neurologie and INSERM U546, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, Paris, France.
Summary
Mutations in the SCN4A gene cause various neuromuscular disorders, including periodic paralyses and myotonias. Clinical presentation varies even with identical mutations, suggesting genetic and epigenetic influences.
Area of Science:
- Molecular biology
- Neuroscience
- Genetics
Background:
- Ion channels are crucial for cellular function, particularly action potential.
- Channelopathies are diseases caused by ion channel dysfunction.
- The SCN4A gene encodes muscle voltage-gated sodium channels implicated in neuromuscular disorders.
Purpose of the Study:
- To review clinical features of skeletal muscle sodium channel diseases.
- To highlight the phenotypic and genetic overlap in these channelopathies.
Main Methods:
- Review of clinical features of SCN4A-related neuromuscular disorders.
- Analysis of genetic and phenotypic data from affected individuals and families.
Main Results:
- Over 30 SCN4A mutations are linked to disorders like periodic paralyses and myotonias.
- Distinct disorders can arise from different SCN4A mutations, and similar phenotypes from different gene mutations.
- Identical SCN4A mutations can manifest differently within families, indicating genetic background influence.
Conclusions:
- SCN4A mutations are a significant cause of skeletal muscle channelopathies.
- Phenotypic variability and overlap are characteristic of these disorders.
- Genetic background and epigenetic factors modulate disease expression.